| The biological and clinical significance of emerging SARS-CoV-2 variants K Tao, PL Tzou, J Nouhin, RK Gupta, T de Oliveira, SL Kosakovsky Pond, ... Nature Reviews Genetics 22 (12), 757-773, 2021 | 1029 | 2021 |
| A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions C Yi, S Troutman, D Fera, A Stemmer-Rachamimov, JL Avila, N Christian, ... Cancer cell 19 (4), 527-540, 2011 | 282 | 2011 |
| Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies M Bonsignori, EF Kreider, D Fera, RR Meyerhoff, T Bradley, K Wiehe, ... Science translational medicine 9 (381), eaai7514, 2017 | 194 | 2017 |
| Non-neutralizing antibodies alter the course of HIV-1 infection in vivo JA Horwitz, Y Bar-On, CL Lu, D Fera, AAK Lockhart, JCC Lorenzi, ... Cell 170 (4), 637-648. e10, 2017 | 158 | 2017 |
| RAG: RNA-As-Graphs database—concepts, analysis, and features HH Gan, D Fera, J Zorn, N Shiffeldrim, M Tang, U Laserson, N Kim, ... Nutrition and Health 5 (1-2), 1285-1291, 1987 | 122 | 1987 |
| RAG: RNA-As-Graphs web resource D Fera, N Kim, N Shiffeldrim, J Zorn, U Laserson, HH Gan, T Schlick BMC bioinformatics 5, 1-9, 2004 | 101 | 2004 |
| Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations WB Williams, J Zhang, C Jiang, NI Nicely, D Fera, K Luo, MA Moody, ... Nature communications 8 (1), 1732, 2017 | 84 | 2017 |
| Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains D Fera, AG Schmidt, BF Haynes, F Gao, HX Liao, TB Kepler, SC Harrison Proceedings of the National Academy of Sciences 111 (28), 10275-10280, 2014 | 84 | 2014 |
| Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies WB Williams, RR Meyerhoff, RJ Edwards, H Li, K Manne, NI Nicely, ... Cell 184 (11), 2955-2972. e25, 2021 | 77 | 2021 |
| Structural analysis of neutralizing epitopes of the SARS-CoV-2 spike to guide therapy and vaccine design strategies MT Finkelstein, AG Mermelstein, E Parker Miller, PC Seth, ESD Stancofski, ... Viruses 13 (1), 134, 2021 | 71 | 2021 |
| Identification and characterization of small molecule human papillomavirus E6 inhibitors KA Malecka, D Fera, DC Schultz, S Hodawadekar, M Reichman, ... ACS chemical biology 9 (7), 1603-1612, 2014 | 68 | 2014 |
| Structural constraints of vaccine-induced tier-2 autologous HIV neutralizing antibodies targeting the receptor-binding site T Bradley, D Fera, J Bhiman, L Eslamizar, X Lu, K Anasti, R Zhang, ... Cell reports 14 (1), 43-54, 2016 | 60 | 2016 |
| Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial D Easterhoff, MA Moody, D Fera, H Cheng, M Ackerman, K Wiehe, ... PLoS pathogens 13 (2), e1006182, 2017 | 58 | 2017 |
| Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins D Fera, DC Schultz, S Hodawadekar, M Reichman, PS Donover, J Melvin, ... Chemistry & biology 19 (4), 518-528, 2012 | 37 | 2012 |
| HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope D Fera, MS Lee, K Wiehe, RR Meyerhoff, A Piai, M Bonsignori, ... Nature communications 9 (1), 1111, 2018 | 32 | 2018 |
| Structure-guided molecular grafting of a complex broadly neutralizing viral epitope G Bajic, MJ Maron, TM Caradonna, M Tian, A Mermelstein, D Fera, ... ACS infectious diseases 6 (5), 1182-1191, 2020 | 22 | 2020 |
| The effects of framework mutations at the variable domain interface on antibody affinity maturation in an HIV-1 broadly neutralizing antibody lineage JO Zhou, HA Zaidi, T Ton, D Fera Frontiers in immunology 11, 1529, 2020 | 17 | 2020 |
| Different regions of the HPV-E7 and Ad-E1A viral oncoproteins bind competitively but through distinct mechanisms to the CH1 transactivation domain of p300 D Fera, R Marmorstein Biochemistry 51 (47), 9524-9534, 2012 | 16 | 2012 |
| A structural update of neutralizing epitopes on the HIV envelope, a moving target E Parker Miller, MT Finkelstein, MC Erdman, PC Seth, D Fera Viruses 13 (9), 1774, 2021 | 11 | 2021 |
| Identification and characterization of a B-Raf kinase α-helix critical for the activity of MEK kinase in MAPK signaling D Nguyen, LY Lin, JO Zhou, E Kibby, TW Sia, TD Tillis, N Vapuryan, ... Biochemistry 59 (50), 4755-4765, 2020 | 6 | 2020 |
